DNA Immunoadsorbent Column
Indication:
Systemic lupus erythematous (SLE), especially for patients with the following symptoms:
1. Severe activity SLE (SLEDAI score ≥ 15)
2. Undesirable high titer of autoantibodies (ANA or anti-ds-DNA antibody exceeds normal range for more than 20%)
3. Combined organ damage (such as lupus nephritis, lupus encephalopathy, etc.)
4. Hormonal or immunosuppressive treatment Intolerance; or patients who do not reach the therapy target by hormonal or immunosuppressive treatment.
Treatment modes:
Properties:
Product parameter | DNA230 |
Loading capacity (ml) | 230±3 |
Volumn(ml) | 150±5 |
Absorbent material | Carbonized resin |
Housing material | Polycarbonate |
Sterilization method | Irradiation sterilization |
Unit package | 255mm(L)×86mm(W)×86mm(H) 0.7kg |